198 related articles for article (PubMed ID: 20230618)
21. A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications.
Voigtlander R; Haase R; Mück-Hausl M; Zhang W; Boehme P; Lipps HJ; Schulz E; Baiker A; Ehrhardt A
Mol Ther Nucleic Acids; 2013 Apr; 2(4):e83. PubMed ID: 23549553
[TBL] [Abstract][Full Text] [Related]
22. Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element.
Papapetrou EP; Ziros PG; Micheva ID; Zoumbos NC; Athanassiadou A
Gene Ther; 2006 Jan; 13(1):40-51. PubMed ID: 16094410
[TBL] [Abstract][Full Text] [Related]
23. Persistence of plasmid-mediated expression of transgenes in human mesenchymal stem cells depends primarily on CpG levels of both vector and transgene.
Bruter AV; Kandarakov OF; Belyavsky AV
J Gene Med; 2018 Feb; 20(2-3):e3009. PubMed ID: 29424052
[TBL] [Abstract][Full Text] [Related]
24. [Maintenance of Plasmid Expression in vivo Depends Primarily on the CpG Contents of the Vector and Transgene].
Bruter AV; Kalashnikova MV; Prytyko AP; Belyavsky AV
Mol Biol (Mosk); 2020; 54(3):487-496. PubMed ID: 32492013
[TBL] [Abstract][Full Text] [Related]
25. Optimization of transcriptional regulatory elements for constructing plasmid vectors.
Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
Gene; 2001 Jul; 272(1-2):149-56. PubMed ID: 11470520
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
27. Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1.
Jenke AC; Wilhelm AD; Orth V; Lipps HJ; Protzer U; Wirth S
Antimicrob Agents Chemother; 2008 Jul; 52(7):2355-9. PubMed ID: 18474581
[TBL] [Abstract][Full Text] [Related]
28. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
Yew NS; Wysokenski DM; Wang KX; Ziegler RJ; Marshall J; McNeilly D; Cherry M; Osburn W; Cheng SH
Hum Gene Ther; 1997 Mar; 8(5):575-84. PubMed ID: 9095409
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
30. Myocardial injection of CA promoter-based plasmid mediates efficient transgene expression in rat heart.
Huang J; Ito Y; Kobune M; Sasaki K; Nakamura K; Dehari H; Takahashi K; Ikeda K; Uchida H; Kato K; Hamada H
J Gene Med; 2003 Oct; 5(10):900-908. PubMed ID: 14533199
[TBL] [Abstract][Full Text] [Related]
31. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
32. Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation.
Chen ZY; Riu E; He CY; Xu H; Kay MA
Mol Ther; 2008 Mar; 16(3):548-56. PubMed ID: 18253155
[TBL] [Abstract][Full Text] [Related]
33. Minimal size MIDGE vectors improve transgene expression in vivo.
Schakowski F; Gorschlüter M; Buttgereit P; Märten A; Lilienfeld-Toal MV; Junghans C; Schroff M; König-Merediz SA; Ziske C; Strehl J; Sauerbruch T; Wittig B; Schmidt-Wolf IG
In Vivo; 2007; 21(1):17-23. PubMed ID: 17354609
[TBL] [Abstract][Full Text] [Related]
34. Cell Compatibility of an Eposimal Vector Mediated by the Characteristic Motifs of Matrix Attachment Regions.
Wang TY; Wang L; Yang YX; Zhao CP; Jia YL; Li Q; Zhang JH; Peng YY; Wang M; Xu HY; Wang XY
Curr Gene Ther; 2016; 16(4):271-277. PubMed ID: 27915978
[TBL] [Abstract][Full Text] [Related]
35. A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro.
Lu J; Zhang F; Kay MA
Mol Ther; 2013 May; 21(5):954-63. PubMed ID: 23459514
[TBL] [Abstract][Full Text] [Related]
36. Functional promoter testing using a modified lentiviral transfer vector.
Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
[TBL] [Abstract][Full Text] [Related]
37. [Effects of Different Promoters and
Li Q; Wang XY; Zhao CP; Tian ZW; Xu DH; Wang TY; Zhang JH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):18-23. PubMed ID: 29737083
[TBL] [Abstract][Full Text] [Related]
38. Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters.
Bockstael O; Chtarto A; Wakkinen J; Yang X; Melas C; Levivier M; Brotchi J; Tenenbaum L
Hum Gene Ther; 2008 Nov; 19(11):1293-305. PubMed ID: 19866492
[TBL] [Abstract][Full Text] [Related]
39. The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences.
Giannakopoulos A; Stavrou EF; Zarkadis I; Zoumbos N; Thrasher AJ; Athanassiadou A
J Mol Biol; 2009 Apr; 387(5):1239-49. PubMed ID: 19248788
[TBL] [Abstract][Full Text] [Related]
40. Corneal gene delivery: chitosan oligomer as a carrier of CpG rich, CpG free or S/MAR plasmid DNA.
Klausner EA; Zhang Z; Wong SP; Chapman RL; Volin MV; Harbottle RP
J Gene Med; 2012 Feb; 14(2):100-8. PubMed ID: 22106057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
